DHR - DANAHER CORP /DE/


194.54
-0.960   -0.493%

Share volume: 7,856,875
Last Updated: 04-21-2026
Measuring And Control Equipment/Industrial Measurement Instruments & Related Products: 0.04%

PREVIOUS CLOSE
CHG
CHG%

$195.50
-0.96
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
55%
Profitability 44%
Dept financing 43%
Liquidity 41%
Performance 72%
Company vs Stock growth
vs
Performance
5 Days
-0.11%
1 Month
2.39%
3 Months
-18.97%
6 Months
-10.80%
1 Year
1.29%
2 Year
-17.60%
Key data
Stock price
$194.54
P/E Ratio 
44.74
DAY RANGE
$190.46 - $200.50
EPS 
$5.07
52 WEEK RANGE
$180.03 - $242.80
52 WEEK CHANGE
-$0.90
MARKET CAP 
161.698 B
YIELD 
0.56%
SHARES OUTSTANDING 
707.139 M
DIVIDEND
$0.40
EX-DIVIDEND DATE
03-27-2026
NEXT EARNINGS DATE
07-22-2025
BETA 
0.56
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,640,902
AVERAGE 30 VOLUME 
$4,001,332
Company detail
CEO: Rainer M. Blair
Region: US
Website: danaher.com
Employees: 81,000
IPO year: 1987
Issue type: Common Stock
Market: NYSE
Industry: Measuring And Control Equipment/Industrial Measurement Instruments & Related Products
Sector: Manufacturing

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics.

Recent news